Editorialists’ replyBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4991 (Published 15 September 2010) Cite this as: BMJ 2010;341:c4991
- John G F Cleland, professor1,
- Klaus Witte, senior lecturer and honorary consultant cardiologist2
- 1Department of Cardiology, Castle Hill Hospital, Hull York Medical School, University of Hull, Kingston upon Hull HU16 5JQ
- 2Division of Diabetes and Cardiovascular Research, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Leeds LS2 9JT
We are heartened by the volume of correspondence that our editorial provoked. The comments fall into three categories: cardiologists knowledge of osteoporosis, meta-analysis, and bisphosphonates.1 The more important issue of why regulation of drugs for chronic diseases must change received little comment. We hope that silence means that most readers agreed with our arguments and that governments have taken note.
Experts are …